A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy

Pomeroy, E. J., Hunzeker, J. T., Kluesner, M. G., Lahr, W. S., Smeester, B. A., Crosby, M. R., Lonetree, C., Yamamoto, K., Bendzick, L., Miller, J. S., Geller, M. A., Walcheck, B., Felices, M., Webber, B. R., Starr, T. K., Moriarity, B. S.  A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy.  Molecular Therapy. 2020; 28(1), 52-63.  doi:10.1016/j.ymthe.2019.10.009